Search

Progyny Inc

Închisă

SectorSănătate

25.57 0.59

Rezumat

Modificarea prețului

24h

Curent

Minim

25.31

Maxim

25.8

Indicatori cheie

By Trading Economics

Venit

28M

52M

Vânzări

22M

351M

P/E

Medie Sector

28.461

57.371

EPS

0.34

Marjă de profit

14.917

Angajați

835

EBITDA

5.9M

44M

Recomandări

By TipRanks

Recomandări

Puternic Cumpărare

Prognoză pe 12 luni

+33.72% upside

Dividende

By Acuity

Următoarele câștiguri

5 nov. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-495M

1.9B

Deschiderea anterioară

24.98

Închiderea anterioară

25.57

Sentimentul știrilor

By Acuity

51%

49%

283 / 340 Clasament în Healthcare

Progyny Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

24 aug. 2026, 19:36 UTC

Progyny Inc shares are lower today, reversing from earlier gains amid market volatility linked to geopolitical tensions and US sanctions against Iran.

20 aug. 2026, 19:31 UTC

News

Wells Fargo initiated coverage on Progyny Inc with an Overweight rating and a $37.00 price target, contributing to the stock's rise during Thursday's session.

18 aug. 2026, 20:06 UTC

Progyny Inc. shares are higher today, reflecting steady gains during the session. The stock remains below its 20-day moving average.

17 aug. 2026, 20:01 UTC

News

Progyny Inc shares are lower following a negative market reaction to its second-quarter earnings and lowered full-year revenue guidance to $1.37 billion.

14 aug. 2026, 20:06 UTC

Progyny Inc shares are higher during Friday's session, despite a recent pullback from earlier highs. Broader market sentiment remains mixed amid declining U.S. retail sales.

13 aug. 2026, 21:31 UTC

Progyny Inc shares are higher in after-market trading, recovering from earlier losses. No specific news was identified to explain the price movement.

12 aug. 2026, 20:01 UTC

News

Progyny Inc shares are lower following a Barclays downgrade, which cut the price target to $30 from $34, citing performance concerns.

11 aug. 2026, 20:02 UTC

News

Progyny Inc's stock is declining after a disappointing revenue forecast, despite strong second-quarter results that exceeded analyst expectations.

7 aug. 2026, 20:02 UTC

News

Progyny Inc's shares are lower after a cautious Q3 sales outlook, despite reporting revenue of $350.5 million that exceeded analyst expectations.

6 aug. 2026, 23:02 UTC

News

Progyny Inc shares are lower in after-market trading following a revenue guidance cut to $1.36 billion to $1.39 billion, below previous estimates.

31 iul. 2026, 19:46 UTC

Progyny Inc shares are lower today amid broader market pressures and rising bond yields. No specific company news was identified to explain the decline.

30 iul. 2026, 21:02 UTC

Progyny Inc shares are lower in after-market hours, with no specific news identified for the decline. The stock is below its 20-day moving average.

29 iul. 2026, 18:55 UTC

Progyny Inc shares are higher today, reflecting notable strength in trading. The stock remains above its 20-day moving average.

28 iul. 2026, 17:41 UTC

News
Social Media

Progyny Inc shares are lower following a downgrade by Barclays, which noted slowing website traffic growth at fertility clinics. Price target raised to $34 from $27.

24 iul. 2026, 15:06 UTC

News

BTIG maintained its Buy rating on Progyny and raised the price target to $40. Shares are trading higher, remaining above the 20-day moving average.

22 iul. 2026, 20:01 UTC

News

Progyny Inc shares are lower despite the acceptance of benefits at Pinnacle Fertility New York, enhancing access to reproductive care for members.

20 iul. 2026, 17:16 UTC

Progyny Inc shares are higher today, maintaining a position near their one-month trading range. No specific news was identified to explain the movement.

Comparație

Modificare preț

Progyny Inc Așteptări

Obiectiv de preț

By TipRanks

33.72% sus

Prognoză pe 12 luni

Medie 34.3 USD  33.72%

Maxim 40 USD

Minim 30 USD

În baza a 10 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruProgyny Inc - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Puternic Cumpărare

10 ratings

8

Cumpărare

2

Păstrare

0

Vânzare

Sentiment

By Acuity

283 / 340 Clasament în Sănătate

Sentimentul știrilor

Evidențe de scădere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Peste medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Progyny Inc

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.
help-icon Live chat